opc 21268 has been researched along with halothane in 1 studies
| Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
|---|---|---|---|---|---|
| 133 | 3 | 6 | 14,369 | 884 | 235 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charles, CJ; Donald, RA; Ikram, H; Prickett, T; Richards, AM | 1 |
1 other study(ies) available for opc 21268 and halothane
| Article | Year |
|---|---|
Arginine vasopressin V1-receptor antagonism in an ovine model of acute myocardial infarction.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Halothane; Hemodynamics; Myocardial Infarction; Piperidines; Quinolones; Renin; Sheep | 1998 |